Atlas Monitor | 21 March 2016
Not satisfied with ruining the lives of many young women, the promoters of HPV vaccines are now targeting young men.
This morning’s Radio NZ National’s ‘Nine To Noon’ show served again as the ever reliable bully pulpit for Big Pharma and the universal vaccination programme agenda. Dr Helen Petoussis-Harris who is the Director of Research at the Immunisation Advisory Centre and Dr Bruce Haughey from Washington University School of Medicine in St. Louis, USA, attempted to frighten RNZ listeners with the dire warning that ‘male cancers caused by the same virus that causes cervical cancer in women are likely to overtake cervical cancer rates by the end of 2020’.
Their solution is to expand New Zealand’s HPV vaccination programme to include boys as well as girls.
The often repeated meme that HPV vaccines are ‘safe and effective’ is contradicted by independent reviews. Dr. Lucija Tomljenovic notes that none of the studies making such claims have been designed to detect adverse reactions such as auto-immune disease.
Some of he latest information and examination of epidemiological studies published in the April 2015 edition of Med Check notes that:
While there is no evidence yet confirming that HPV vaccination decreases the incidence of and mortality from cervical cancer, assuming that the vaccine could halve cervical cancer mortality, the expected maximum benefit would be 2.0 deaths per 100,000 person-years. Hence, the harm experienced to date is overwhelmingly greater than the benefit expected.
As the harms of HPV vaccine became well known, many serious adverse reaction cases were reported long after injection including unprecedented “severe reactions”, which were completely new even to specialists in neurology and collagen disease of childhood. Because the risk of autoimmune disease is estimated to be several hundred-times higher and even the excess fatalities higher than the maximum expected preventable cervical cancer death risk by several orders of ten; so, the harms are definitely unacceptable. The MHLW and the manufacturers should admit the causality of the HPV vaccine in serious adverse reactions as soon as possible. HPV vaccine should be withdrawn from the market and all women inoculated with HPV vaccine should be followed up.
Debate has been raging for years between pro and anti vaccination proponents. A recent study published in a prestigious Canadian medical journal Vaccine, that raised safety questions over the HPV vaccine, was consequently censored after individuals linked to the pharmaceutical industry (Merck in particular) complained to the journal’s editor.
The attacks on researchers who have raised concerns about the safety and effectiveness of vaccines has taken a sinister turn with revelations that some have died under suspicious circumstances. In some of these cases the doctors are said to have discovered cancer enzymes in vaccines.
This claim is not entirely new and in fact was openly admitted by vaccine pioneer Dr Maurcice Hilleman who made jokes about the fact that Merck drug company vaccines (Polio) had been deliberately contaminated with SV40, a cancer-causing monkey virus from 1953 to 1963.
RNZ’s guests on this morning’s ‘Nine To Noon’ show are demonstrably biased and have a political agenda.
The case against the HPV vaccine is overwhelming. The so-called studies that claim it is ‘safe and effective’ are not designed to detect any problems.
There are over 100 strains of the HPV of which 14 can cause cancerous lesions. Vaccines such as Gardasil claim to offer protection against only two. The disclosure by government agencies that thousands of girls in the UK have reported serious life threatening injuries cannot be ignored so easily.
With regards to cancer the discussion we should be having should ask when and why did cancer shift from being caused by DNA damage to being caused by a virus? There is excellent research that demonstrates compellingly that this occurred in the 1960s when cancer was weaponized in US military research labs and put into vaccines (e.g. SV-40 virus [1] and HeLA cells [2]).
The NZ Herald reports today that, according to the Ministry of Health, New Zealand has a ‘good safety profile’.
More than 200,000 New Zealand females have received the vaccine since 2008. By last June, 568 cases of adverse reactions had been reported following vaccination, including 41 considered serious.
The ministry, citing overseas authorities and New Zealand’s Medicines Adverse Reactions Committee, says they have found “no association between HPV immunisations and a range of health conditions including chronic fatigue syndrome, auto-immune conditions, multiple sclerosis, complex regional pain syndrome, postural orthostatic tachycardia syndrome and sudden death”.
According to information held by MedSafe, between 2008 and 2016 the number of reported reactions is 1225. A detailed breakdown follows below.
Adverse reactions reported for Human Papillomavirus Vaccine between 1 Jan 2008 and 1 Jan 2016
Number of reports for Human papillomavirus vaccine: 500
Number reports where death was reported: 0
Number of reactions: 1225
System Organ Class | MedDRA Reaction Term | Number of Reports |
---|---|---|
Blood and lymphatic system disorders | Lymphadenopathy | 7 |
Lymphopenia | 1 | |
Thrombocytopenia | 1 | |
Cardiac disorders | Bradycardia | 1 |
Cyanosis | 2 | |
Palpitations | 2 | |
Tachycardia | 6 | |
Ear and labyrinth disorders | Ear pain | 1 |
Tinnitus | 2 | |
Vertigo | 2 | |
Eye disorders | Conjunctival haemorrhage | 1 |
Diplopia | 1 | |
Eye movement disorder | 1 | |
Eye pain | 1 | |
Lacrimation increased | 1 | |
Mydriasis | 4 | |
Periorbital oedema | 5 | |
Photophobia | 3 | |
Pupillary reflex impaired | 1 | |
Vision blurred | 8 | |
Visual impairment | 3 | |
Gastrointestinal disorders | Abdominal discomfort | 3 |
Abdominal distension | 1 | |
Abdominal pain | 25 | |
Diarrhoea | 8 | |
Hypoaesthesia oral | 1 | |
Lip swelling | 3 | |
Nausea | 77 | |
Paraesthesia oral | 1 | |
Swollen tongue | 3 | |
Tongue disorder | 2 | |
Vomiting | 56 | |
General disorders and administration site conditions | Asthenia | 1 |
Chest discomfort | 2 | |
Chest pain | 6 | |
Chills | 9 | |
Face oedema | 5 | |
Fatigue | 20 | |
Feeling cold | 1 | |
Feeling hot | 3 | |
Feeling of body temperature change | 4 | |
Gait disturbance | 2 | |
Influenza like illness | 5 | |
Injection site bruising | 3 | |
Injection site erythema | 10 | |
Injection site inflammation | 35 | |
Injection site mass | 6 | |
Injection site pain | 30 | |
Injection site pruritus | 10 | |
Injection site rash | 1 | |
Injection site swelling | 2 | |
Injection site urticaria | 1 | |
Localised oedema | 3 | |
Malaise | 3 | |
Oedema peripheral | 3 | |
Pain | 1 | |
Pyrexia | 67 | |
Immune system disorders | Anaphylactic reaction | 1 |
Serum sickness-like reaction | 1 | |
Infections and infestations | Conjunctivitis | 2 |
Injection site abscess | 1 | |
Otitis media | 1 | |
Urinary tract infection | 1 | |
Injury, poisoning and procedural complications | Laceration | 1 |
Investigations | Blood iron decreased | 2 |
C-reactive protein increased | 1 | |
Laboratory test abnormal | 1 | |
Metabolism and nutrition disorders | Dehydration | 1 |
Hyperglycaemia | 1 | |
Hypoglycaemia | 1 | |
Musculoskeletal and connective tissue disorders | Arthralgia | 11 |
Back pain | 2 | |
Bone pain | 1 | |
Bursitis | 1 | |
Limb discomfort | 1 | |
Mobility decreased | 1 | |
Muscle spasms | 2 | |
Muscle twitching | 3 | |
Muscular weakness | 14 | |
Musculoskeletal pain | 6 | |
Musculoskeletal stiffness | 2 | |
Myalgia | 25 | |
Pain in extremity | 55 | |
Nervous system disorders | Amnesia | 1 |
Ataxia | 2 | |
Depressed level of consciousness | 6 | |
Disturbance in attention | 1 | |
Dizziness | 73 | |
Dysaesthesia | 4 | |
Dysarthria | 2 | |
Dysgeusia | 1 | |
Generalised tonic-clonic seizure | 1 | |
Headache | 109 | |
Hyperaesthesia | 2 | |
Hypertonia | 1 | |
Hypoaesthesia | 23 | |
Hypokinesia | 3 | |
Hypotonia | 1 | |
Lethargy | 13 | |
Memory impairment | 1 | |
Migraine | 8 | |
Muscle contractions involuntary | 5 | |
Muscle spasticity | 1 | |
Myoclonus | 1 | |
Neuropathy peripheral | 1 | |
Paraesthesia | 15 | |
Petit mal epilepsy | 1 | |
Presyncope | 72 | |
Seizure | 7 | |
Somnolence | 13 | |
Speech disorder | 1 | |
Syncope | 5 | |
Tremor | 9 | |
Psychiatric disorders | Abnormal behaviour | 1 |
Affect lability | 2 | |
Affective disorder | 2 | |
Anxiety | 6 | |
Confusional state | 2 | |
Depression | 1 | |
Hallucination | 1 | |
Insomnia | 1 | |
Irritability | 1 | |
Nervousness | 1 | |
Nightmare | 1 | |
Panic reaction | 1 | |
Sleep disorder | 1 | |
Reproductive system and breast disorders | Amenorrhoea | 1 |
Menorrhagia | 1 | |
Menstrual disorder | 1 | |
Respiratory, thoracic and mediastinal disorders | Anoxia | 1 |
Apnoea | 1 | |
Bronchospasm | 3 | |
Cough | 2 | |
Dysphonia | 1 | |
Dyspnoea | 11 | |
Epistaxis | 1 | |
Hyperventilation | 2 | |
Oropharyngeal pain | 6 | |
Pharyngeal oedema | 1 | |
Respiratory disorder | 1 | |
Rhinorrhoea | 1 | |
Stridor | 1 | |
Tachypnoea | 1 | |
Throat irritation | 3 | |
Throat tightness | 5 | |
Skin and subcutaneous tissue disorders | Alopecia | 3 |
Angioedema | 4 | |
Cold sweat | 2 | |
Dermatitis bullous | 1 | |
Eczema | 2 | |
Erythema | 2 | |
Erythema multiforme | 1 | |
Henoch-Schonlein purpura | 1 | |
Hyperhidrosis | 1 | |
Night sweats | 1 | |
Pityriasis rosea | 1 | |
Pruritus | 17 | |
Purpura | 3 | |
Rash | 32 | |
Rash erythematous | 6 | |
Rash macular | 7 | |
Rash maculo-papular | 4 | |
Rash morbilliform | 1 | |
Rash papular | 2 | |
Rash pruritic | 11 | |
Rash vesicular | 2 | |
Skin discolouration | 1 | |
Skin exfoliation | 1 | |
Skin mass | 1 | |
Urticaria | 23 | |
Surgical and medical procedures | Abortion induced | 1 |
[1] Horowitz, Leonard G. Emerging viruses : AIDS and Ebola : nature, accident, or intentional? Tetrahedron, 1996; see also Haslam, Edward T. Dr. Mary’s monkey : how the unsolved murder of a doctor, a secret laboratory in New Orleans and cancer-causing monkey viruses are linked to Lee Harvey Oswald, the JFK assassination and emerging global epidemics, TimeDay, 2014 (updated ed.)